Hyperprolactinemia as a marker of neurotransmitter imbalance in uremic population.
Serum prolactin (PRL) levels are elevated in patients with chronic renal failure (CRF) but the mechanisms responsible for these abnormalities are not fully understood. PRL secretion is undoubtedly influenced by many substances, which can be variously altered in uremia: monoamines, endogenous opiates and PTH. Our data suggest that in early renal failure PRL levels are already significantly high and the 24-h pattern of PRL secretion is significantly different from that in controls. PRL derangements could be due in mild renal failure, to unknown factors (GABA?); in severe CRF, to a major change in dopaminergic activity; in hemodialysis (HD), to a low turnover of monoamines, and in peritoneal dialysis (PD) to increased activity of serotoninergic and dopaminergic systems.
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000209:etiology* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000502:physiology*; D010530:Peritoneal Dialysis; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D006435:Renal Dialysis; D014511:Uremia / Q000097:blood / Q000150:complications* / Q000503:physiopathology / Q000628:therapy
D018377:Neurotransmitter Agents; D011388:Prolactin